|
Volumn 97, Issue 4, 2006, Pages 477-479
|
Benefits of niacin in patients with versus without the metabolic syndrome and healed myocardial infarction (from the Coronary Drug Project)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
PLACEBO;
ADULT;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EDUCATION PROGRAM;
FOLLOW UP;
HEART INFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
METABOLIC SYNDROME X;
MORTALITY;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
TREATMENT OUTCOME;
ANTILIPEMIC AGENTS;
CHOLESTEROL, HDL;
FOLLOW-UP STUDIES;
HUMANS;
METABOLIC SYNDROME X;
MYOCARDIAL INFARCTION;
NIACIN;
RECURRENCE;
TREATMENT OUTCOME;
|
EID: 31944438344
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2005.08.070 Document Type: Article |
Times cited : (125)
|
References (8)
|